Skip to main content
Premium Trial:

Request an Annual Quote

DeltaDot Partners with Qatar in Proteomics Center

NEW YORK (GenomeWeb News) – DeltaDot will partner with the Qatar Science and Technology Park to open a proteomics research and testing services lab in Doha, the London-based company said on Monday.

Under the plan, QSTP will contribute $15 million to the partnership, while DeltaDot will provide staff, expertise, and it will grant QSTP an exclusive regional license to its technology.

Projects already in the works include biomarker studies for breast cancer and colorectal cancer and the metallic content of proteins, the company said.

The center will use DeltaDot's Label Free Intrinsic Imaging technology to develop new proteomics tools. The agreement also enables DeltaDot QSTP to market DeltaDot's products in the Middle East and North Africa region.

Eulian Roberts, who is managing director of QSTP, said in a statement that the agreement fits with Qatar's plans to become a center of scientific research by 2030.

DeltaDot CEO Paul James said in a statement that the venture will help the company develop its technology and applications and expand its life sciences offerings, and that the center will serve as "a core facility to attract new ventures to the region."

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.